// App-Quantinova.ai

7034 : Impact of complete molecular response (CMR) on survival in patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL).

Researchers

Presenter

  • Nicholas James Short

Principal Investigators

  • Elias Jabbour

  • Jorge E. Cortes

  • Rebecca Garris

  • Susan Mary O'Brien

  • Keyur Patel

  • Koji Sasaki

  • Ghayas C. Issa

  • Guillermo Garcia-Manero

  • Deborah A. Thomas

  • Hagop M. Kantarjian

  • Farhad Ravandi

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • University of California, Irvine, Fullerton, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 206

Drug/Treatment

  • Ponatinib

  • dasatinib

  • Imatinib

  • IkT001

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved